Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies

被引：0
|
作者：
Glenn A.Harris [1 ]
Lauren R.Hirschfeld [1 ]
机构：
[1] Rainwater Charitable Foundation
来源：
NeuralRegenerationResearch | 2025年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R741 [神经病学];
学科分类号：
摘要：
Tauopathies are a group of neurodegenerative diseases characterized by abnormal metabolism of the misfolded tau protein. Tau is encoded by the microtubule-associated protein tau gene(MAPT) and can be classified as either 3-repeat(3R) or 4-repeat(4R) based on the number of repeat domains from alternative splicing of exon 10 of the MAPT gene.
引用
收藏
页码：803 / 804
页数：2
相关论文
共 50 条
  • [21] ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL
    STEIN, CA
    CHENG, YC
    SCIENCE, 1993, 261 (5124) : 1004 - 1012
  • [22] Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
    Sazani, P
    Kole, R
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (04): : 481 - 486
  • [23] Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
    Moreno, Pedro M. D.
    Pego, Ana P.
    FRONTIERS IN CHEMISTRY, 2014, 2
  • [24] Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
    Cakan, Elif
    Lara, Olivia D.
    Szymanowska, Anna
    Bayraktar, Emine
    Chavez-Reyes, Arturo
    Lopez-Berestein, Gabriel
    Amero, Paola
    Rodriguez-Aguayo, Cristian
    CANCERS, 2024, 16 (17)
  • [25] Splice-switching antisense oligonucleotides as therapeutic drugs
    Havens, Mallory A.
    Hastings, Michelle L.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (14) : 6549 - 6563
  • [26] Antisense oligonucleotides: local delivery enhances their therapeutic potential
    Nyce, JW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (03) : 263 - 267
  • [27] Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
    Anderson, Brooke A.
    Freestone, Graeme C.
    Low, Audrey
    De-Hoyos, Cheryl L.
    Drury, William J., III
    Ostergaard, Michael E.
    Migawa, Michael T.
    Fazio, Michael
    Wan, W. Brad
    Berdeja, Andres
    Scandalis, Eli
    Burel, Sebastien A.
    Vickers, Timothy A.
    Crooke, Stanley T.
    Swayze, Eric E.
    Liang, Xuehai
    Seth, Punit P.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (16) : 9026 - 9041
  • [28] Antisense oligonucleotides: a promising therapeutic option against infectious diseases
    Tekintas, Yamac
    Temel, Aybala
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024, 43 (01): : 1 - 39
  • [29] PROSPECTS FOR THE THERAPEUTIC USE OF ANTISENSE OLIGONUCLEOTIDES IN MALIGNANT-LYMPHOMAS
    MAGRATH, IT
    ANNALS OF ONCOLOGY, 1994, 5 : S67 - S70
  • [30] Mechanism of antisense oligonucleotides and their use in gene therapy as a therapeutic agent
    Ruzdijic, S
    Rakic, L
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 1998, 17 (03): : 133 - 133
12345